SE9003296L - Foerfarande foer att formulera laekemedel - Google Patents

Foerfarande foer att formulera laekemedel

Info

Publication number
SE9003296L
SE9003296L SE9003296A SE9003296A SE9003296L SE 9003296 L SE9003296 L SE 9003296L SE 9003296 A SE9003296 A SE 9003296A SE 9003296 A SE9003296 A SE 9003296A SE 9003296 L SE9003296 L SE 9003296L
Authority
SE
Sweden
Prior art keywords
pellets
pct
dosage
date apr
cohesive
Prior art date
Application number
SE9003296A
Other languages
English (en)
Other versions
SE9003296D0 (sv
Inventor
A Kristensen
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9003296A priority Critical patent/SE9003296L/sv
Publication of SE9003296D0 publication Critical patent/SE9003296D0/sv
Publication of SE9003296L publication Critical patent/SE9003296L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
SE9003296A 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel SE9003296L (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel
DE1991615711 DE69115711D1 (de) 1990-10-16 1991-10-15 Verfahren zur arzneiformulierung sowie arzneimittel
DK91918066T DK0553169T3 (da) 1990-10-16 1991-10-15 Fremgangsmåde til lægemiddelformulering samt farmaceutisk middel
PCT/SE1991/000690 WO1992006679A1 (en) 1990-10-16 1991-10-15 A method for drug formulation and a pharmaceutical composition
US08/039,175 US5476667A (en) 1990-10-16 1991-10-15 Method for drug formulation and a pharmaceutical composition
AU87459/91A AU650683B2 (en) 1990-10-16 1991-10-15 Melt granulating method for drug formulation
JP51707291A JP3459011B2 (ja) 1990-10-16 1991-10-15 薬物配合方法及び医薬組成物
DE1991615711 DE69115711T2 (de) 1990-10-16 1991-10-15 Verfahren zur arzneiformulierung sowie arzneimittel
AT91918066T AT131727T (de) 1990-10-16 1991-10-15 Verfahren zur arzneiformulierung sowie arzneimittel
CA 2094030 CA2094030C (en) 1990-10-16 1991-10-15 A method for drug formulation and a pharmaceutical composition
EP19910918066 EP0553169B1 (en) 1990-10-16 1991-10-15 A method for drug formulation and a pharmaceutical composition
ES91918066T ES2081498T3 (es) 1990-10-16 1991-10-15 Un metodo para la formulacion de farmacos y una composicion farmaceutica.
IE362791A IE74194B1 (en) 1990-10-16 1991-10-16 A method for drug formulation and a pharmaceutical composition
PT9924591A PT99245B (pt) 1990-10-16 1991-10-16 Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem
GR960400760T GR3019360T3 (en) 1990-10-16 1996-03-19 A method for drug formulation and a pharmaceutical composition

Publications (2)

Publication Number Publication Date
SE9003296D0 SE9003296D0 (sv) 1990-10-16
SE9003296L true SE9003296L (sv) 1992-04-17

Family

ID=20380654

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel

Country Status (14)

Country Link
US (1) US5476667A (sv)
EP (1) EP0553169B1 (sv)
JP (1) JP3459011B2 (sv)
AT (1) AT131727T (sv)
AU (1) AU650683B2 (sv)
CA (1) CA2094030C (sv)
DE (2) DE69115711D1 (sv)
DK (1) DK0553169T3 (sv)
ES (1) ES2081498T3 (sv)
GR (1) GR3019360T3 (sv)
IE (1) IE74194B1 (sv)
PT (1) PT99245B (sv)
SE (1) SE9003296L (sv)
WO (1) WO1992006679A1 (sv)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
AT212224T (de) * 1993-11-23 2002-02-15 Euro Celtique Sa Verfahren zur herstellung einer arzneizusammensetzung mit verzögerter wirkstoffabgabe
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
IL109460A (en) * 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
IL109944A (en) 1993-07-01 1998-12-06 Euro Celtique Sa Sustained release dosage unit forms containing morphine and a method of preparing these sustained release dosage unit forms
AU8010494A (en) * 1993-09-29 1995-04-18 E.I. Du Pont De Nemours And Company Melt granulation with dielectric heating
GB2284760B (en) * 1993-11-23 1998-06-24 Euro Celtique Sa A method of preparing pharmaceutical compositions by melt pelletisation
EP0672416A1 (en) * 1994-03-14 1995-09-20 Euro-Celtique S.A. Pharmaceutical composition comprising diamorphine
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
CA2360655C (en) 1999-01-29 2007-03-20 Losan Pharma Gmbh Pharmaceutical compositions
US6248718B1 (en) 1999-08-18 2001-06-19 Atlantic Biomed Corporation Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2305218A1 (en) 1999-10-29 2011-04-06 Euro-Celtique S.A. Controlled release hydrocodone formulations
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
KR101167465B1 (ko) 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
WO2005000237A2 (en) * 2003-06-25 2005-01-06 University Of Tennessee Research Foundation Granules containing biologically active substances
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
NZ549661A (en) 2004-02-06 2010-07-30 Pharmatel R & D Pty Ltd As Tru Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP1972335A1 (en) * 2007-03-23 2008-09-24 Krka Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
FR2918277B1 (fr) * 2007-07-06 2012-10-05 Coretecholding Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
KR101560176B1 (ko) 2007-10-31 2015-10-14 맥네일-피피씨, 인코포레이티드 구강내 붕해성 투여 형태
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
FR3014317B1 (fr) 2013-12-11 2016-04-22 Patrice Binay Nouveau procede de fabrication de formulations pharmaceutiques transmuqueuses et formations ainsi obtenues
US9789066B2 (en) 2014-01-10 2017-10-17 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE2360796B2 (de) * 1973-12-06 1977-06-02 Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
US4129666A (en) * 1977-04-29 1978-12-12 Walter Wizerkaniuk Method of providing pellets with a water insoluble coating using a melt
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten

Also Published As

Publication number Publication date
SE9003296D0 (sv) 1990-10-16
PT99245A (pt) 1992-09-30
CA2094030C (en) 2003-06-17
GR3019360T3 (en) 1996-06-30
DE69115711T2 (de) 1996-05-30
AT131727T (de) 1996-01-15
JP3459011B2 (ja) 2003-10-20
IE74194B1 (en) 1997-07-16
IE913627A1 (en) 1992-04-22
CA2094030A1 (en) 1992-04-17
PT99245B (pt) 1999-04-30
US5476667A (en) 1995-12-19
AU8745991A (en) 1992-05-20
EP0553169A1 (en) 1993-08-04
AU650683B2 (en) 1994-06-30
EP0553169B1 (en) 1995-12-20
DE69115711D1 (de) 1996-02-01
DK0553169T3 (da) 1996-05-13
JPH06502151A (sv) 1994-03-10
WO1992006679A1 (en) 1992-04-30
ES2081498T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
US3147187A (en) Sustained release pharmaceutical
DE2965725D1 (en) Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
TW504389B (en) Stable glassy state powder formulations
TW557217B (en) Pharmaceutical dry powder compositions for use in treating respiratory disorders and the process for preparing the same
ES2040339T3 (es) Procedimiento para preparar un granulo farmaceutico.
ES2029269T3 (es) Un metodo de fabricacion de una formulacion de liberacion lenta.
HUT45023A (en) Process for production of derivatives of 1,5-diphenilpirasole-carbonic acid and selective herbicides containing these compositions as antidotum and derivatives of phenoxipropion acid as herbicide active substance
AR057636A2 (es) Procedimiento para preparar una composicion farmaceutica que contiene ibandronato en forma de dosificacion unitaria
HUT53359A (en) Process for producing pharmaceutical compositions comprising oxooxazolinidyl cyclopentano benzene derivatives as active ingredient
HUT62455A (en) Power gas comprising tg 227 (1,1,1,2,3,3,3-heptafluoropropane and process for producing pharmaceutical compositions by using this power gas
HUT61324A (en) Process for producing rhombic cyclosporin consisting of globular particles and new pulmonary pharmaceutical compositions comprising same as active ingredient
ES478736A1 (es) Procedimiento para la preparacion de un granulado de poli( alcohol vinilico) que contiene agente plasificante.
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
CL2004001182A1 (es) Composicion farmaceutica que comprende a una microparticula de liberacion sostenida la que contiene a un derivado de 1,2 benzazol; procedimiento de preparacion de la microparticula; util como broncodilatador, antipsicoticos y en otros problemas del s
CA2166891A1 (en) Method for making freeze dried drug dosage forms
GEP20002013B (en) Therapeutical Means
GR880100799A (el) Μέ?οδος παρασκευής τσίχλας με επικαλυμμένα με κερί συστατικά επιβραδυνομένης απόδοσης.
HUT51862A (en) Insecticides containing as active substance nitrocompositions and process for production of these compositions
JPH0297414A (en) Production of active carbon having superior quality
ES479602A1 (es) Procedimiento para la preparacion de aditivos solidos con velocidad ajustable de disgregacion para aglutinantes que seendurecen con agua.
HUT50332A (en) Process for producing acetylene derivatives disubstituted with heteroaromatic and heterobicyclic group and pharmaceutical compositions comprising these compounds as active ingredient
DE2964530D1 (en) 2,3,4,5-tetrahydro-1h-3-benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity
HUT51865A (en) Herbicides containing as active substance derivatives of salycil acid or their sulfhur-analoges, further compositions regulating the growt of plants containing salycil acid derivatives and process for production of the active substances
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
MD4C2 (ro) Remediu erbicid

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9003296-2

Format of ref document f/p: F